EcoDrugPlus

Cyclin Dependent Kinase 7

Ensembl ID : ENSPLAG00000004680
Gene Symbol: CDK7
3 Cross references
218 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSPLAG00000020266
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cyclin-Dependent Kinase 2

Ensembl ID : ENSPLAG00000019066
Gene Symbol: LOC106954702
3 Cross references
202 Possible Orthologues:

Cyclin-Dependent Kinase 4-Like

Ensembl ID : ENSPLAG00000009092
Gene Symbol: LOC106961113
3 Cross references
238 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSPLAG00000009624
Gene Symbol: CYSLTR1
1 Cross references
172 Possible Orthologues:

Cytidine Deaminase-Like

Ensembl ID : ENSPLAG00000005371
Gene Symbol: LOC106955125
3 Cross references
200 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSPLAG00000013932
Gene Symbol: LOC106962756
3 Cross references
194 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSPLAG00000002046
Gene Symbol: LOC106940464
2 Cross references
130 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSPLAG00000003175
Gene Symbol: LOC106944029
2 Cross references
142 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSPLAG00000002086
Gene Symbol: LOC106940465
2 Cross references
130 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSPLAG00000000154
Gene Symbol: LOC106941173
2 Cross references
76 Possible Orthologues:

Cytochrome P450 3a56

Ensembl ID : ENSPLAG00000020449
Gene Symbol: LOC106943213
3 Cross references
145 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).